Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 196 entries
View as:

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Phase: N/A Priority: Normal
NCT ID: NCT02401373 Org: User:
Start: 03/31/15 End: 07/31/15 Due: 07/31/16

Clinical Evaluation of Chronic Consciousness Disorders Using Resting-state EEG and ERP

Phase: N/A Priority: Normal
NCT ID: NCT05949528 Org: User:
Start: 12/12/21 End: 06/30/24 Due: 06/30/25

Baricitinib in Idiopathic Granulomatous Mastitis

Phase: N/A Priority: Normal
NCT ID: NCT05852171 Org: User:
Start: 05/04/23 End: 12/31/25 Due: 12/31/26

Three Induction Treatments on Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT04072640 Org: User:
Start: 01/25/21 End: 12/01/22 Due: 12/01/23

The Association of Microbiota Composition With cGVHD After Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT05355675 Org: User:
Start: 05/01/22 End: 05/31/25 Due: 05/31/26

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Phase: N/A Priority: Normal
NCT ID: NCT04423965 Org: User:
Start: 05/12/20 End: 05/01/25 Due: 05/01/26

Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel

Phase: N/A Priority: Normal
NCT ID: NCT04715802 Org: User:
Start: 10/18/06 End: 12/31/25 Due: 12/31/26

Comparative Study of Insulin Therapy Between Inner and Outer Upper Thigh

Phase: N/A Priority: Normal
NCT ID: NCT02307968 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02816944 Org: User:
Start: 05/31/16 End: 06/30/18 Due: 06/30/19

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

Phase: N/A Priority: Normal
NCT ID: NCT04391283 Org: User:
Start: 07/27/20 End: 12/31/24 Due: 12/31/25

Efficacy and Safety of Jaktinib in Patients With COVID-19 Pneumonia.

Phase: N/A Priority: Normal
NCT ID: NCT05672888 Org: User:
Start: 03/31/23 End: 05/31/24 Due: 05/31/25

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT04778839 Org: User:
Start: 03/04/21 End: 12/31/24 Due: 12/31/25

Comparison of EMR-P With Conventional EMR

Phase: N/A Priority: Normal
NCT ID: NCT04191473 Org: User:
Start: 05/01/20 End: 12/31/20 Due: 12/31/21

CTA-MCI: Cognitive Control Training in Patients With Amnestic Mild Cognitive Impairment(CTA-MCI)

Phase: N/A Priority: Normal
NCT ID: NCT03133052 Org: User:
Start: 07/09/17 End: 04/30/20 Due: 04/30/21

Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness

Phase: N/A Priority: Normal
NCT ID: NCT03809936 Org: User:
Start: 04/02/19 End: 12/31/20 Due: 12/31/21

SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases

Phase: N/A Priority: Normal
NCT ID: NCT06850103 Org: User:
Start: 03/28/25 End: 12/31/32 Due: 12/31/33

18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.

Phase: N/A Priority: Normal
NCT ID: NCT06164561 Org: User:
Start: 11/21/23 End: 12/31/25 Due: 12/31/26

Immunoprofilling of Peripheral Blood Mononuclear Cells in Children With Attention Deficit/Hyperactivity Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06109337 Org: User:
Start: 12/04/23 End: 12/31/27 Due: 12/31/28

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06278038 Org: User:
Start: 02/22/24 End: 11/19/24 Due: 11/19/25

Efficacy and Safety Assessment of Temporal Interference Stimulation to Improve Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT07021508 Org: User:
Start: 05/20/25 End: 05/31/26 Due: 05/31/27

Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06782763 Org: User:
Start: 12/20/24 End: 09/01/25 Due: 09/01/26

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.

Phase: N/A Priority: Normal
NCT ID: NCT06371274 Org: User:
Start: 10/15/24 End: 04/30/26 Due: 04/30/27

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

Phase: N/A Priority: Normal
NCT ID: NCT06081582 Org: User:
Start: 07/06/23 End: 11/30/24 Due: 11/30/25

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Phase: N/A Priority: Normal
NCT ID: NCT04694248 Org: User:
Start: 11/03/21 End: 06/30/26 Due: 06/30/27

CD Patients Immune Status Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT04135482 Org: User:
Start: 10/21/19 End: 07/31/20 Due: 07/31/21